
Plasma P-tau181/Aβ42 ratio may be a noninvasive means of identifying AD with elevated brain amyloid in populations with concomitant CeVD.
Authors: Joyce R. Chong, Nicholas J. Ashton, Thomas K. Karikari, Tomotaka Tanaka, Francis N. Saridin, Anthonin Reilhac, Edward G. Robins, Ying‐Hwey Nai, Henri A. Vrooman, Saima Hilal, Henrik Zetterberg, Kaj Blennow, Mitchell K.P. Lai, Christopher Chen
DOI: https://doi.org/10.1002/alz.12332
Publish Year: 2021